Murrysville, PA, November 16, 2006 – Respironics, Inc. (NASDAQ/NMS Symbol: RESP) announced today the availability of a new Pediatric Asthma Management Program featuring new characters, Tucker the TurtleSM and Sami the SealSM. The program features “Tucker Tackles Asthma,” a bilingual (English/Spanish) Coloring and Activity book. Through the pages and puzzles of the book, families will come together to meet Tucker and Sami – two friends who learn through their adventures how to take control of asthma and learn how to live a normal, playful life. The characters help teach kids how to manage asthma using a peak flow meter, valved holding chamber and a nebulizer to take medications. The book also features fun stickers that can be used to decorate the child’s asthma management products.
“Living with asthma can be a challenge for anyone and especially for children,” said Laura Bartelt, Associate Product Manager. “Our new characters Tucker and Sami help to make it easier and more fun for kids to learn how to control asthma symptoms and monitor their condition,” she explained.
 |
The Coloring and Activity book is included in a new AsthmaPACK™ Children's Asthma Care Kit which contains:
- Personal Best® Low Range Peak Flow Meter
- OptiChamber® Advantage Valved Holding Chamber
- Instructional DVD and Asthma Care Booklet (English/Spanish)
- 'Tucker Tackles Asthma' Coloring and Activity Book with Fun Stickers (English/Spanish)
- Crayons (pack of 4)
- Carrying Case
 |
AsthmaPACKs are available in several other product configurations for patients of all ages, and are widely used in hospitals and other healthcare institutions.
Respironics Respiratory Drug Delivery is dedicated to advancing pulmonary aerosol delivery technologies for the treatment of respiratory and non-respiratory diseases. Through the development of innovative devices and on-going research, its goal is to be the leading provider of breakthrough solutions for pharmaceutical companies, healthcare providers, and their patients, at all points of care. Products include nebulizer systems, holding chambers and spacers, and intelligent drug delivery systems that enable the delivery of precise and reproducible doses of drug to the lung regardless of a patient’s age and size, disease state or breathing pattern.
Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and health care providers. Respironics markets its products in 131 countries and employs over 4,700 associates worldwide. Further information can be found on the Company’s Web site: www.respironics.com.
# # #
This document contains forward-looking statements, including statements relating to, among other things, developments in the healthcare industry; the success of the Company’s marketing, sales, and promotion programs; future sales and acceptance of the Company’s products and programs; the timing and success of new product introductions; new product development; anticipated cost savings; FDA and other regulatory requirements and enforcement actions; future results from acquisitions; acquisition integration; growth rates in foreign markets; regulations and other factors affecting operations and sales outside the United States (including potential future effects of the change in sovereignty of Hong Kong); foreign currency fluctuations; customer consolidation and concentration; increasing price competition and other competitive factors in the sale of products; interest rate fluctuations; expiration of intellectual property rights; intellectual property and related litigation; other litigation; future levels of earnings and revenues; and third party reimbursement, all of which are subject to change. Actual results may differ materially from those described in any forward-looking statements. Additional information on potential factors that could affect the Company’s financial results are included in the reports filed with the SEC, including the reports on Form 10-K, 10-Q and 8-K.
© 2006 Respironics, Inc. and its affiliates. All rights reserved.
My Respironics | Suppliers | Clinicians | Media Resource Library | Contact Us
All Rights Reserved | Privacy Notice | Terms & Conditions | Site Map